ArticleFrontiers in endocrinology2026
A preconception to late pregnancy community cohort study for reference values of serum thyrotropin and total thyroxine.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Population-based preconception cohort studies to establish reference ranges for thyroid function tests during pregnancy are scarce. This study was done to establish the reference values for thyrotropin (TSH) and total thyroxine (T4) during the first and late-second trimesters in preconceptionally euthyroid, thyroid autoantibody-negative, community-dwelling pregnant women in a South-Indian district. Methods: Newly married nulliparous women aged 18-35 years from were recruited preconceptionally using multistage cluster sampling. Baseline pre-conceptional thyroid function, including TSH, Total T4, and anti-Thyroid peroxidase(TPO) antibodies, was assessed. Women who were euthyroid and negative for TPO antibodies were included and followed throughout pregnancy, with repeat thyroid function tests during the first and second trimesters. Results: Of the 1507 women enrolled, 482 pregnancies were identified during the 18-month follow up period. Among these, 182 met the inclusion criteria, with 125 assessed in the first trimester and 120 in the second trimester. The first-trimester TSH reference range was found to be 0.1-3.9 µIU/mL, and the second trimester range was 0.7-4.6 µIU/mL. Total T4 reference ranges were 5.2-17.0 µg/dL and 7.6-14.7 µg/dL, respectively. In the longitudinally studied women, TSH decreased from 2.3 ± 1.0 µIU/mL pre-pregnancy to 1.6 ± 1.0 µIU/mL in the first trimester, then rose marginally to 2.0 ± 0.7 µIU/mL in the second trimester. First-trimester TSH levels correlated positively with pre-pregnancy TSH and with abdominal circumference in these anti-TPO negative women (p=0.01). Conclusion: This study establishes community-based trimester-specific reference intervals for TSH and Total T4 in preconceptionally euthyroid, TPO antibody negative community dwelling Indian women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.